We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
-2.89%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$935M
AUM Growth
+$227M
Cap. Flow
+$310M
Cap. Flow %
33.15%
Top 10 Hldgs %
70.78%
Holding
86
New
20
Increased
18
Reduced
12
Closed
29

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$32.9M
2
LLY icon
Eli Lilly
LLY
+$18.6M
3
FIVN icon
FIVE9
FIVN
+$11.3M
4
NICE icon
Nice
NICE
+$11.2M
5
META icon
Meta Platforms (Facebook)
META
+$9.65M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$26.7M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$16.3M
3
KYMR icon
Kymera Therapeutics
KYMR
+$15.6M
4
ZIM icon
ZIM Integrated Shipping Services
ZIM
+$10.8M
5
GNRC icon
Generac Holdings
GNRC
+$9.81M

Sector Composition

Rank Sector Weight
1 Healthcare 47.28%
2 Technology 3.05%
3 Communication Services 0.86%
4 Financials 0.27%
5 Consumer Discretionary 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
S icon
76
SentinelOne
S
$6.53B
– –
-65,000
Closed -$2.52M
SWTX
77
CALL
DELISTED
SpringWorks Therapeutics
SWTX
– –
-125,000
Closed -$7.05M
TEVA icon
78
PUT
Teva Pharmaceuticals
TEVA
$40.8B
– –
-210,000
Closed -$1.97M
VRNA
79
DELISTED
Verona Pharma
VRNA
– –
-666,339
Closed -$3.33M
ZIM icon
80
ZIM Integrated Shipping Services
ZIM
$3.04B
– –
-148,000
Closed -$10.8M
LIAN
81
DELISTED
LianBio American Depositary Shares
LIAN
– –
-275,007
Closed -$1.02M
AYLA
82
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
– –
-250,000
Closed -$995K
IS
83
DELISTED
ironSource Ltd.
IS
– –
-620,000
Closed -$2.98M
1 2 3
4

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2022 Portfolio in Review

As of Q2 2022, Sphera Funds Management held 86 positions worth $935M, up 32% from $708M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Sphera Funds Management deployed $310M of net new capital in Q2 2022, opening 20 new positions and adding to 18 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 437,748 shares worth $32.5M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 72% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Generac Holdings, an estimated $9.81M trimmed.

  • Sphera Funds Management's largest Q2 2022 buy was State Street SPDR S&P Biotech ETF: 437,748 shares worth $32.5M.
  • Sphera Funds Management added most to Eli Lilly in Q2 2022, an estimated $18.6M increase.
  • Sphera Funds Management's biggest Q2 2022 reduction was Generac Holdings, cutting an estimated $9.81M.
  • Sphera Funds Management fully exited Pfizer in Q2 2022, selling an estimated $26.7M.
  • Sphera Funds Management's ten largest holdings make up 71% of its $935M portfolio in Q2 2022.
  • Sphera Funds Management opened 20 new positions and closed 29 in Q2 2022.
  • Sphera Funds Management's portfolio value rose 32% quarter-over-quarter to $935M.

Based on Sphera Funds Management's 13F filing for Q2 2022, filed 15 Aug 2022.